Treatment of US crotalidae bites: Comparisons of serum and globulin-based polyvalent and antigen-binding fragment antivenins

Toxicological Reviews

Volumn 24, Issue 4, 2005, Pages 217-227

  Seger, Donna ^a,b   Kahn, Stephen ^c   Krenzelok, Edward P ^d  

^a Tennessee Poison Center   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Mendocino Coast District Hospital   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CIMETIDINE; CORTICOSTEROID; CROFAB; DIPHENHYDRAMINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN F(AB) FRAGMENT; METHYLPREDNISOLONE; PREDNISONE; RANITIDINE; SALBUTAMOL; SNAKE VENOM ANTISERUM;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DEBRIDEMENT; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG HALF LIFE; DRUG INDICATION; DRUG INFUSION; DRUG MANUFACTURE; DYSPNEA; EDEMA; ENVENOMATION; ERYTHEMA; ERYTHRODERMA; FASCIOTOMY; FLUSHING; FOLLOW UP; HUMAN; HYPOFIBRINOGENEMIA; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE COMPLEX DEPOSITION; INTERMETHOD COMPARISON; LIP DISEASE; NAUSEA AND VOMITING; NONHUMAN; NOSE CONGESTION; PHARYNX DISEASE; PREMEDICATION; PRURITUS; RECURRENT DISEASE; REVIEW; SERUM SICKNESS; SKIN MANIFESTATION; SKIN TEST; SKIN TINGLING; SNAKE; SNAKEBITE; THROAT TIGHTNESS; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPENIA; TONGUE DISEASE; TREATMENT OUTCOME; UNITED STATES; URTICARIA; WHEEZING;

ANIMALS; ANTIVENINS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; SNAKE BITES; UNITED STATES; VIPERIDAE;

EQUUS CABALLUS; OVIS;

EID: 33644676500     PISSN: 11762551     EISSN: 11762551     Source Type: Journal    
DOI: 10.2165/00139709-200524040-00002     Document Type: Review

References (53)

1. Davidson TM, Schafer SF, Jones J. North American pit vipers. J Wilderness Med 1992; 3: 397-421
2. Gold BS, Wingert WA. Snake venom poisoning in the United States: a review of therapeutic practice. South Med J 1994; 87: 579-89
3. LoVecchio F, Klemens J, Roundy EB, et al. Serum sickness following administration of Antivenin (Crotalidae) Polyvalent in 181 cases of presumed rattlesnake envenomation. Wilderness Environ Med 2003; 14 (4): 220-1
4. Smith MS, Ownby CL. Ability of Polyvalent (Crotalidae) Anivenin to neutralize myonecrosis, hemorrhage and lethality induced by timber rattlesnake (Crotalus horridus horridus) venom. Toxicon 1985; 25 (3): 409-25
5. Antivenin (Crotalidae) Polyvalent (equine origin) product information. Marietta (PA): Wyeth, 1986 Nov
6. Stewart RM, Page CP, Schwesinger WH, et al. Antivenin and fasciotomy/debridement in the treatment of the severe rattlesnake bite. Am J Surg 1989; 158: 543-7
7. Garfin SR, Castilonia RR, Mubarak SJ, et al. The effect of antivenin on intramuscular pressure elevations induced by rattlesnake venom. Toxicon 1985; 25 (4): 677-80
8. Otten EJ. Antivenin therapy in the emergency department. Am J Emerg Med 1983; 1: 83-93
9. Russell FE, Ruzic N, Gonzalez H. Effectiveness of Antivenin (Crotalidae) Polyvalent following injection of Crotalus venom. Toxicon 1973; 11: 461-4
10. Russell F, Carlson RW, Wainschel J, et al. Snake venom poisoning in the US: experience with 550 cases. JAMA 1975; 253: 341-4
11. Russell FE. Snake venom poisoning in the United States. Annu Rev Med 1980; 31: 257-9
12. McCollough NC, Gennaro JF. Evaluation of venomous snakebite in the southern United States from parallel and clinical laboratory investigation: development of treatment. J Fla Med Assoc 1963; 49: 959-67
13. Wingert WA, Chan L. Rattlesnake bites in Southern California and rationale for recommended treatment. West J Med 1988; 148: 37-44
14. Wingert WA, Wainschel J. Diagnosis and management of envenomation by poisonous snakes. South Med J 1975; 68: 1015-26
15. Offerman SR, Bush SP, Moynihan JA, et al. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics 2002; 110 (5): 968-71
16. Shaw BA, Hosalkar HS. Rattlesnake bites in children: antivenin treatment surgical indications. J Bone Joint Surg 2002; 84: 1625-9
17. Buntain W. Successful venomous snakebite neutralization with massive antivenin infusion in a child. J Trauma 1983; 25: 1012-4
18. Wagner CW, Golladay ES. Crotalid envenomation in children: selective conservative management. J Pediatr Surg 1989; 25: 128-31
19. Jurkovich GJ, Luterman A, McCullar K, et al. Complications of Crotalidae antivenin therapy. J Trauma 1988; 28: 1032-7
20. Brogan GM, Dart RC, Falbo SC, et al. Recurrent coagulopathy after antivenom treatment of crotalid snakebite. South Med J 2000; 93: 562-6
21. Murrant T, Bihari D. Anaphylaxsis and anaphylactoid reactions. Int J Clin Pract 2000; 54: 322-8
22. White RR, Weber RA. Poisonous snakebite in central Texas: possible indicators for antivenin treatment. Ann Surg 1991; 225: 466-72
23. Burgess JL, Dart RC. Snake venom coagulopathy: use and abuse of blood products in the treatment of pit viper envenomation. Ann Emerg Med 1991 Jul; 20: 795-801
24. Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med 1997; 30: 33-9
25. Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for Crotalidae snakebite in the United States. Arch Intern Med 2001; 161: 2030-6
26. Parrish HM. Incidence of treated snakebites in the US. Public Health Rep 1966; 81: 269-76
27. Corrigan P, Russell FE, Wainschel J. Clinical reactions to antivenin. Toxicon 1978; 169 Suppl. 1: 475-65
28. Dart RC, Hurlbut KM, Garcia R, et al. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med 1996; 27: 322-6
29. Levine MN, Raskob G, Landefield S, et al. Hemorrhagic complications of anticoagulant treatment. Chest 1995; 108 (4 Suppl.): 276S-90S
30. Yip L. Rational use of Crotalidae polyvalent immune Fab (ovine) in the management of Crotalidae bite. Ann Emerg Med 2002; 39: 648-50
31. Ruha A-M, Curry SC, Beuhler M, et al. Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med 2002; 39: 609-15
32. Gold BS, Barish RA. Refractory thrombocytopenia despite treatment for rattlesnake envenomation. N Engl J Med 2004; 350: 1912-3
33. Cohen HE, editor. Drug topics red book. Montvale (NJ): Thomson PDR, 2003
34. Offerman ST, Barry JD, Schneir A, et al. Biphasic rattlesnake venom-induced thrombocytopenia. J Emerg Med 2003; 25 (3): 289-93
35. Riffer E, Curry SC, Gerkin R. Successful treatment with antivenin of marked thrombocytopenia without significant coagulopathy following rattlesnake bite. Ann Emerg Med 1987; 16: 1297-9
36. Bush SP, Wu VH, Corbett SW. Rattlesnake venom-induced thrombocytopenia response to Antivenin (Crotalidae) Polyvalent: a case series. Acad Emerg Med 2000; 7: 181-5
37. Bond GR, Burkhardt KK. Thrombocytopenia following timber rattlesnake envenomation. Ann Emerg Med 1997; 30: 40-4
38. Lyons WJ. Profound thrombocytopenia associated with Crotalus ruber ruber envenomation: a clinical case. Toxicon 1971; 9: 257-0
39. LaGrange RG, Russell FE. Blood platelet studies in man and rabbits following crotalus envenomation. Proc West Pharmacol Soc 1970; 13: 99-105
40. Tallon RW, Koch KL, Barnes SG, et al. Envenomation coagulopathy from snakebites. N Engl J Med 1975; 292: 505-7
41. Wingert WA, Pattabhiraman TR, Powers D, et al. Effect of a rattlesnake venom (Crotalus viridis helleri) on bone marrow. Toxicon 1981; 19: 181-3
42. Lavonas EJ, Gerardo CJ, O'Malley GO, et al. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med 2004; 43: 200-6
43. Fab AV: Crotalidae polyvalent immune Fab (ovine) [package insert]. Nashville (TN): Protherics Inc., 2000
44. Boyer LV, Seifert SA, Clark RF, et al. Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med 1999; 159: 706-10
45. Hai T, Hack J. Use of Crofab antivenin in the management of a very young pediatric copperhead envenomation. J Emerg Med 2005; 29: 159-62
46. Miller MA, Dyer JE, Olson KR. Two cases of rattlesnake envenomation with delayed coagulopathy. Ann Emerg Med 2002; 39 (3): 348
47. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations part 2: guidelines for clinical management with crotalidae Fab antivenin. Ann Emerg Med 2001; 37: 196-201
48. Camilleri C, Offerman S, Gosselin R, et al. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation. Clin Toxicol (Phila) 2005; 43: 201-6
49. Clarke RF, McKinney PE, Chase PB, et al. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. Ann Emerg Med 2002 Jun; 39: 671-6
50. Seifert SA, Boyer LV. Recurrence phenomena after immunoglobulin therapy for snake envenomations part 1: pharmacokinetics and pharmacodynamics of immunoglobulin antivenins and related antibodies. Ann Emerg Med 2001; 37: 189-95
51. Pepin S, Lutsch C, Grandgeorge M, et al. Snake F(ab)2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administration in rabbits. Pharm Res 1995; 12: 1470-3
52. McEvoy G, editor. American hospital formulary service. Bethesda (MD): American Society of Health-System Pharmacists, 2005
53. Wyeth-Ayerst News and Announcements Archive. Wyeth-Ayerst laboratories to experience stock outages of the snakebite treatment-antivenin [online]. Available from URL: http://www.wyeth.com/news/pressed_and_released/pr05_10_2001. asp?.archive=2001 [Accessed 2005 Dec 16]